 |
|
|
| |
Novel HIV PI with High Resistance Barrier
and Potential for Unboosted QD Oral Dosing
|
| |
| |
Reported by Jules Levin
CROI 2017 Feb 14-16 Seattle, WA
John O. Link, Darryl Kato, Michael Moore, Andrew Mulato, Bernard Murray, Judy Mwangi, Nathan Shapiro, George Stepan, Yujin Wang, Zeng-Yu Yang
Gilead Sciences, Inc., Foster City, CA
WEBCAST:http://www.croiwebcasts.org/console/player/33636?mediaType=slideVideo&
|
| |
|
|
|
|
|
